Skip to main content

Table 4 Patient outcomes

From: Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-

n = 9

No. of patients

Clinical Response

 

PD/SD/PR/CR (Response rate)

0/2/7/0 (78%)

Level 1

0/1/2/0

Level 2

0/0/3/0

Level 3

0/1/2/0

Surgery

 

Distal/Total

4/4

D1/D2

0/8

R0/R1/R2

8/0/0

Operation time (min)

249 (195–288)

Blood loss (ml)

578 (110–1700)

Postoperative complication

 

Stump leakage

1

Pancreatic fistula

1

Chylous ascites

1

Histological therapeutic effect

 

Grade 1a/1b/2/3

2/1/4/1

  1. PD: Progressive disease; SD: Stable disease; PR: Partial response; CR: Complete response; Distal: Distal gastrectomy; Total: Total gastrectomy; D1: Limited lymphadenectomy; D2: Extended lymphadenectomy; R0: No residual tumor; R1: Microscopic residual tumor; R2: Macroscopic residual tumor.